Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keefe

Showing results (191-200 of 255) with videos related to

Pageof 26
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|May 4, 2010
Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controlsN Segarra, M Bernardo, F Gutierrez, et al.
Psychological Assessment|March 9, 2011
Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophreniaSteven P Reise, Joseph Ventura, Richard S E Keefe, et al.
Schizophrenia Research|January 11, 2021
Exploring the role of age as a moderator of cognitive remediation for people with schizophreniaBenedetta Seccomandi, Deborah Agbedjro, Morris Bell, et al.
Schizophrenia Research|May 27, 2015
Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairmentS Kristian Hill, Alison Buchholz, Hayley Amsbaugh, et al.
Schizophrenia Research|December 10, 2015
Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relativesW C Hochberger, S K Hill, C L M Nelson, et al.
The American Journal of Psychiatry|January 4, 2008
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization StudyMichael F Green, Keith H Nuechterlein, Robert S Kern, et al.
JAMA Psychiatry|October 16, 2024
Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta-AnalysisLena Feber, Natalie L Peter, Virginia Chiocchia, et al.
The American Journal of Psychiatry|March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE studyT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Schizophrenia Research|June 15, 2010
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognitionJoseph Ventura, Steven P Reise, Richard S E Keefe, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Pageof 26

Showing results (191-200 of 255) with videos related to

Sort By:
Pageof 26
European Psychiatry : the Journal of the Association of European Psychiatrists|May 4, 2010
Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controlsN Segarra, M Bernardo, F Gutierrez, et al.
Psychological Assessment|March 9, 2011
Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophreniaSteven P Reise, Joseph Ventura, Richard S E Keefe, et al.
Schizophrenia Research|January 11, 2021
Exploring the role of age as a moderator of cognitive remediation for people with schizophreniaBenedetta Seccomandi, Deborah Agbedjro, Morris Bell, et al.
Schizophrenia Research|May 27, 2015
Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairmentS Kristian Hill, Alison Buchholz, Hayley Amsbaugh, et al.
Schizophrenia Research|December 10, 2015
Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relativesW C Hochberger, S K Hill, C L M Nelson, et al.
The American Journal of Psychiatry|January 4, 2008
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization StudyMichael F Green, Keith H Nuechterlein, Robert S Kern, et al.
JAMA Psychiatry|October 16, 2024
Antipsychotic Drugs and Cognitive Function: A Systematic Review and Network Meta-AnalysisLena Feber, Natalie L Peter, Virginia Chiocchia, et al.
The American Journal of Psychiatry|March 3, 2007
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE studyT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Schizophrenia Research|June 15, 2010
The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognitionJoseph Ventura, Steven P Reise, Richard S E Keefe, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychoticT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Pageof 26